S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
MarketBeat Week in Review – 6/4 - 6/9
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
FuelCell Is Back To Realistic Valuation
New Mexico reaches $500M settlement with Walgreens in opioid case
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
Nigeria's central bank chief arrested after being suspended by president
American Airlines, JetBlue seek to keep some ties despite losing antitrust case
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
Oregon Democratic Party to send federal officials a $500,000 donation from former FTX executive
Ukrainian President Volodymyr Zelenskyy says ‘counteroffensive, defensive actions’ taking place in war with Russia
S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
MarketBeat Week in Review – 6/4 - 6/9
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
FuelCell Is Back To Realistic Valuation
New Mexico reaches $500M settlement with Walgreens in opioid case
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
Nigeria's central bank chief arrested after being suspended by president
American Airlines, JetBlue seek to keep some ties despite losing antitrust case
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
Oregon Democratic Party to send federal officials a $500,000 donation from former FTX executive
Ukrainian President Volodymyr Zelenskyy says ‘counteroffensive, defensive actions’ taking place in war with Russia
S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
MarketBeat Week in Review – 6/4 - 6/9
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
FuelCell Is Back To Realistic Valuation
New Mexico reaches $500M settlement with Walgreens in opioid case
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
Nigeria's central bank chief arrested after being suspended by president
American Airlines, JetBlue seek to keep some ties despite losing antitrust case
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
Oregon Democratic Party to send federal officials a $500,000 donation from former FTX executive
Ukrainian President Volodymyr Zelenskyy says ‘counteroffensive, defensive actions’ taking place in war with Russia
S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
MarketBeat Week in Review – 6/4 - 6/9
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
FuelCell Is Back To Realistic Valuation
New Mexico reaches $500M settlement with Walgreens in opioid case
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
Nigeria's central bank chief arrested after being suspended by president
American Airlines, JetBlue seek to keep some ties despite losing antitrust case
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
Oregon Democratic Party to send federal officials a $500,000 donation from former FTX executive
Ukrainian President Volodymyr Zelenskyy says ‘counteroffensive, defensive actions’ taking place in war with Russia
LON:AGL

ANGLE (AGL) Share Forecast, Price & News

GBX 17.50
-0.25 (-1.41%)
(As of 06/9/2023 ET)
Compare
Today's Range
16.70
17.85
50-Day Range
17
27.70
52-Week Range
15.30
115.58
Volume
396,187 shs
Average Volume
2.45 million shs
Market Capitalization
£45.60 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
GBX 120

ANGLE MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
585.7% Upside
GBX 120 Price Target
Short Interest
N/A
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.29mentions of ANGLE in the last 14 days
Based on 4 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.65 out of 5 stars


AGL stock logo

About ANGLE (LON:AGL) Stock

ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products. The company develops and commercializes Parsortix cell separation system, which captures and harvests circulating tumor cells in metastatic breast cancer patient blood; and HyCEAD multiplex analysis system for routine and focused multiplex analysis of DNA, RNA or protein biomarkers. The company was founded in 1994 and is based in Guildford, the United Kingdom.

Receive AGL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ANGLE and its competitors with MarketBeat's FREE daily newsletter.

AGL Stock News Headlines

The single greatest medical breakthrough of all time?
We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.
ANGLE Announces Senior Management Appointments
ANGLE (LON:AGL) Rating Reiterated by Berenberg Bank
ANGLE's long-serving chairman to step down
The single greatest medical breakthrough of all time?
We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.
Airfield Ground Lighting (AGL) Systems Market
ANGLE (LON:AGL) Stock Rating Reaffirmed by Berenberg Bank
ANGLE plc: ANGLE Presentation Via Investor Meet Company
ANGLE Presentation Via Investor Meet Company
ANGLE plc: ANGLE Announces Partnership With BioView
ANGLE and partner to develop breakthrough breast cancer assay
ANGLE study flags potential new use for its technology
ANGLE Parsortix Poster Presented at AACR 2023
ANGLE inks pharma services contract
Angles in polygons
See More Headlines

AGL Price History

AGL Company Calendar

Last Earnings
1/30/2020
Today
6/10/2023

Industry, Sector and Symbol

Industry
Medical Laboratories & Research
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
102
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
GBX 120
High Stock Price Forecast
GBX 120
Low Stock Price Forecast
GBX 120
Forecasted Upside/Downside
+585.7%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
£-21,690,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£1.04 million
Cash Flow
GBX 3.01 per share
Book Value
GBX 15 per share

Miscellaneous

Free Float
N/A
Market Cap
£45.60 million
Optionable
Not Optionable
Beta
0.43

Key Executives

  • Mr. Andrew David William Newland (Age 61)
    Founder, CEO & Exec. Director
    Comp: $446k
  • Mr. Ian Francis Griffiths (Age 58)
    CFO, Fin. Director, Company Sec. & Exec. Director
    Comp: $284k
  • Mr. Martin Cooke (Age 54)
    Director of Operations & Regulatory Affairs
  • Mr. Andrew John Holder (Age 55)
    Head of Investor Relations
  • Mr. Paul Smith
    Chief Commercial Officer
  • Dr. Madeline Repollet
    Head of Clinical Laboratories
  • Ms. Anne-Sophie Pailhes-Jimenez
    Head of R&D - ANGLE Europe Ltd.
  • Mr. Michael O'Brien
    Bus. Devel. Director













AGL Stock - Frequently Asked Questions

Should I buy or sell ANGLE stock right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for ANGLE in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" AGL shares.
View AGL analyst ratings
or view top-rated stocks.

What is ANGLE's stock price forecast for 2023?

1 brokerages have issued 12 month price targets for ANGLE's shares. Their AGL share price forecasts range from GBX 120 to GBX 120. On average, they predict the company's stock price to reach GBX 120 in the next twelve months. This suggests a possible upside of 585.7% from the stock's current price.
View analysts price targets for AGL
or view top-rated stocks among Wall Street analysts.

How have AGL shares performed in 2023?

ANGLE's stock was trading at GBX 50.50 on January 1st, 2023. Since then, AGL shares have decreased by 65.3% and is now trading at GBX 17.50.
View the best growth stocks for 2023 here
.

How were ANGLE's earnings last quarter?

ANGLE plc (LON:AGL) announced its quarterly earnings data on Thursday, January, 30th. The company reported ($3.33) earnings per share (EPS) for the quarter.

What other stocks do shareholders of ANGLE own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ANGLE investors own include Yamana Gold (YRI), Asiamet Resources (ARS), Dekel Agri-Vision (DKL), Eldorado Gold (ELD), Polo Resources (POL), Silvercorp Metals (SVM), First Majestic Silver (AG), AFPO.L (AFPO), Ariana Resources (AAU) and Alamos Gold (AGI).

What is ANGLE's stock symbol?

ANGLE trades on the London Stock Exchange (LON) under the ticker symbol "AGL."

How do I buy shares of ANGLE?

Shares of AGL stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is ANGLE's stock price today?

One share of AGL stock can currently be purchased for approximately GBX 17.50.

How much money does ANGLE make?

ANGLE (LON:AGL) has a market capitalization of £45.60 million and generates £1.04 million in revenue each year. The company earns £-21,690,000.00 in net income (profit) each year or GBX (0.09) on an earnings per share basis.

How many employees does ANGLE have?

The company employs 102 workers across the globe.

How can I contact ANGLE?

ANGLE's mailing address is The Surrey Research Park 3 Frederick Sanger Road, GUILDFORD, GU2 7YD, United Kingdom. The official website for the company is www.angleplc.com. The company can be reached via phone at +44-1483-685830.

This page (LON:AGL) was last updated on 6/10/2023 by MarketBeat.com Staff

My Account -